Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-22 to 2024-05-22
Current total value of award: $3.35
Description: 4564687841!BUPIVACAINE HYDROCHLO